As per Intent Market Research, the Automated CPR Devices Market was valued at USD 212.9 million in 2024-e and will surpass USD 412.9 million by 2030; growing at a CAGR of 11.7% during 2025 - 2030.
The automated CPR (cardiopulmonary resuscitation) devices market is experiencing significant growth, driven by advancements in medical technology, increased awareness of sudden cardiac arrest (SCA), and the growing need for efficient, life-saving solutions. Automated CPR devices are designed to provide consistent, high-quality chest compressions during cardiac arrest, which is a critical factor in improving survival rates. These devices offer a more standardized approach to performing CPR, addressing challenges such as human fatigue and inconsistent compression depth and rate, which are common issues with manual CPR.
The market is also influenced by the increasing adoption of automated external defibrillators (AEDs) in both public and healthcare settings, as these devices play a crucial role in the chain of survival. With a rising incidence of cardiovascular diseases and other health conditions that increase the risk of cardiac arrest, automated CPR devices are being recognized as essential tools in emergency medical care. As the technology continues to evolve, more advanced and user-friendly devices are entering the market, further driving the growth of the automated CPR devices market.
Mechanical Chest Compression Devices Are Largest Device Type Owing to Their Efficiency and Reliability
Mechanical chest compression devices are the largest device type in the automated CPR devices market, owing to their efficiency and reliability in delivering consistent chest compressions during cardiac arrest. These devices use mechanical means to provide compressions at the correct depth and rate, which has been shown to improve patient outcomes compared to manual CPR. The use of mechanical chest compression devices eliminates human error and fatigue, ensuring high-quality CPR in both hospital and pre-hospital settings.
The adoption of mechanical chest compression devices is particularly prominent in emergency medical services (EMS) and hospital environments, where timely and precise CPR is critical for patient survival. These devices are designed to be portable, allowing EMS personnel to transport patients while delivering continuous compressions. The proven efficacy of mechanical chest compression devices in improving survival rates has made them a preferred choice in resuscitation protocols, making them the leading device type in the market.
External Defibrillator Devices Are Fastest Growing Device Type Owing to Their Increased Use in Public Spaces
External defibrillator devices are the fastest-growing device type in the automated CPR devices market, driven by their increased use in public spaces and non-medical settings. Automated external defibrillators (AEDs) are designed for use by both healthcare professionals and laypersons, allowing anyone to perform life-saving defibrillation in cases of sudden cardiac arrest. The increasing deployment of AEDs in public areas, such as airports, schools, shopping malls, and sports venues, has contributed significantly to the growth of this segment.
The growth in AED adoption is also supported by regulatory initiatives and public health campaigns that emphasize the importance of early defibrillation in the survival of cardiac arrest victims. AEDs are easy to use, with automated voice prompts guiding users through the process, making them accessible to individuals without medical training. As more AEDs are installed in public spaces and workplaces, the demand for these devices continues to rise, making them the fastest-growing segment in the automated CPR devices market.
Emergency Medical Services (EMS) Are Largest End-User Owing to High Demand for Life-Saving Equipment
Emergency medical services (EMS) are the largest end-user in the automated CPR devices market, owing to the critical role that these devices play in providing life-saving interventions during cardiac emergencies. EMS teams are often the first responders to sudden cardiac arrest incidents, and the ability to provide high-quality CPR immediately is essential for improving survival chances. Automated CPR devices, such as mechanical chest compression devices and AEDs, are integral to the EMS toolkit, ensuring that resuscitation efforts are consistent and effective during transport and in pre-hospital settings.
EMS providers also benefit from the portability and ease of use of automated CPR devices, which allow them to administer continuous chest compressions and defibrillation while on the move. With the increasing focus on improving survival rates for cardiac arrest victims and the growing recognition of the importance of early intervention, EMS remains the largest end-user segment in the market. The widespread adoption of automated CPR devices within EMS systems has significantly contributed to the market's expansion.
North America Is Largest Region Owing to Advanced Healthcare Systems and High Prevalence of Cardiac Arrest
North America is the largest region in the automated CPR devices market, owing to its advanced healthcare systems, high prevalence of cardiac arrest, and widespread adoption of life-saving technologies. The United States, in particular, has seen a significant increase in the use of automated CPR devices, driven by healthcare policies that promote the availability of AEDs in public spaces and hospitals. The region benefits from strong regulatory support, including initiatives from organizations such as the American Heart Association, which encourage the use of automated CPR devices as part of resuscitation protocols.
In addition, North America has a well-established emergency medical services infrastructure that supports the integration of mechanical chest compression devices and AEDs into emergency care practices. The availability of advanced healthcare technologies, coupled with a high level of awareness about the importance of early defibrillation and CPR, has made North America the largest market for automated CPR devices. As public and private sector investments in healthcare infrastructure continue to grow, North America is expected to maintain its dominant position in the market.
Leading Companies and Competitive Landscape
The automated CPR devices market is highly competitive, with several key players leading the development and commercialization of life-saving technologies. Leading companies in this market include Zoll Medical Corporation, Physio-Control (a subsidiary of Stryker Corporation), Medtronic, and Laerdal Medical. These companies have pioneered the development of automated external defibrillators (AEDs) and mechanical chest compression devices, and they continue to innovate in the field of cardiac arrest management.
The competitive landscape is characterized by ongoing technological advancements, with companies focusing on improving device portability, ease of use, and efficacy. As the market expands, there is also growing interest in the development of devices that integrate with other healthcare technologies, such as telemedicine platforms and electronic health records, to provide more comprehensive care. Strategic partnerships, mergers, and acquisitions are common in this market, as companies seek to enhance their product offerings and gain a competitive edge. The growing demand for automated CPR devices, especially in public spaces and EMS settings, is expected to drive further competition and innovation in the market.
Recent Developments:
- In December 2024, ZOLL Medical Corporation launched an upgraded version of its LUCAS chest compression device, improving portability and ease of use.
- In November 2024, Medtronic (Physio-Control) announced the expansion of its automated CPR device portfolio with the introduction of a new external defibrillator integrated with chest compression technology.
- In October 2024, Laerdal Medical and Ambu A/S partnered to enhance CPR training devices with augmented reality capabilities for better education in emergency settings.
- In September 2024, Stryker Corporation acquired a medical robotics company specializing in automated CPR systems for use in both hospitals and EMS.
- In August 2024, HeartSine Technologies unveiled a compact, portable automated CPR device tailored for use in home care settings and small clinics.
List of Leading Companies:
- ZOLL Medical Corporation
- Physio-Control (Medtronic)
- Stryker Corporation
- Laerdal Medical
- Ambu A/S
- Reanimator Inc.
- Cardiac Science Corporation
- Asahi Kasei Medical Co.
- HeartSine Technologies
- Everst Medical
- Micro Medical Devices
- Infinivault LLC
- Biotronik GmbH & Co. KG
- Vyaire Medical Inc.
- Defibtech LLC
Report Scope:
Report Features |
Description |
Market Size (2024-e) |
USD 212.9 million |
Forecasted Value (2030) |
USD 412.9 million |
CAGR (2025 – 2030) |
11.7% |
Base Year for Estimation |
2024-e |
Historic Year |
2023 |
Forecast Period |
2025 – 2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
Automated CPR Devices Market By Device Type (Mechanical Chest Compression Devices, External Defibrillator Devices), By End-User (Hospitals and Clinics, Emergency Medical Services (EMS), Home Care) |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
Major Companies |
ZOLL Medical Corporation, Physio-Control (Medtronic), Stryker Corporation, Laerdal Medical, Ambu A/S, Reanimator Inc., Cardiac Science Corporation, Asahi Kasei Medical Co., HeartSine Technologies, Everst Medical, Micro Medical Devices, Infinivault LLC, Biotronik GmbH & Co. KG, Vyaire Medical Inc., Defibtech LLC |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
1. Introduction |
1.1. Market Definition |
1.2. Scope of the Study |
1.3. Research Assumptions |
1.4. Study Limitations |
2. Research Methodology |
2.1. Research Approach |
2.1.1. Top-Down Method |
2.1.2. Bottom-Up Method |
2.1.3. Factor Impact Analysis |
2.2. Insights & Data Collection Process |
2.2.1. Secondary Research |
2.2.2. Primary Research |
2.3. Data Mining Process |
2.3.1. Data Analysis |
2.3.2. Data Validation and Revalidation |
2.3.3. Data Triangulation |
3. Executive Summary |
3.1. Major Markets & Segments |
3.2. Highest Growing Regions and Respective Countries |
3.3. Impact of Growth Drivers & Inhibitors |
3.4. Regulatory Overview by Country |
4. Automated CPR Devices Market, by Device Type (Market Size & Forecast: USD Million, 2023 – 2030) |
4.1. Mechanical Chest Compression Devices |
4.1.1. LUCAS (Life-saving) |
4.1.2. Autopulse |
4.2. External Defibrillator Devices |
5. Automated CPR Devices Market, by End-User (Market Size & Forecast: USD Million, 2023 – 2030) |
5.1. Hospitals and Clinics |
5.2. Emergency Medical Services (EMS) |
5.3. Home Care |
5.4. Others |
6. Regional Analysis (Market Size & Forecast: USD Million, 2023 – 2030) |
6.1. Regional Overview |
6.2. North America |
6.2.1. Regional Trends & Growth Drivers |
6.2.2. Barriers & Challenges |
6.2.3. Opportunities |
6.2.4. Factor Impact Analysis |
6.2.5. Technology Trends |
6.2.6. North America Automated CPR Devices Market, by Device Type |
6.2.7. North America Automated CPR Devices Market, by End-User |
6.2.8. By Country |
6.2.8.1. US |
6.2.8.1.1. US Automated CPR Devices Market, by Device Type |
6.2.8.1.2. US Automated CPR Devices Market, by End-User |
6.2.8.2. Canada |
6.2.8.3. Mexico |
*Similar segmentation will be provided for each region and country |
6.3. Europe |
6.4. Asia-Pacific |
6.5. Latin America |
6.6. Middle East & Africa |
7. Competitive Landscape |
7.1. Overview of the Key Players |
7.2. Competitive Ecosystem |
7.2.1. Level of Fragmentation |
7.2.2. Market Consolidation |
7.2.3. Product Innovation |
7.3. Company Share Analysis |
7.4. Company Benchmarking Matrix |
7.4.1. Strategic Overview |
7.4.2. Product Innovations |
7.5. Start-up Ecosystem |
7.6. Strategic Competitive Insights/ Customer Imperatives |
7.7. ESG Matrix/ Sustainability Matrix |
7.8. Manufacturing Network |
7.8.1. Locations |
7.8.2. Supply Chain and Logistics |
7.8.3. Product Flexibility/Customization |
7.8.4. Digital Transformation and Connectivity |
7.8.5. Environmental and Regulatory Compliance |
7.9. Technology Readiness Level Matrix |
7.10. Technology Maturity Curve |
7.11. Buying Criteria |
8. Company Profiles |
8.1. ZOLL Medical Corporation |
8.1.1. Company Overview |
8.1.2. Company Financials |
8.1.3. Product/Service Portfolio |
8.1.4. Recent Developments |
8.1.5. IMR Analysis |
*Similar information will be provided for other companies |
8.2. Physio-Control (Medtronic) |
8.3. Stryker Corporation |
8.4. Laerdal Medical |
8.5. Ambu A/S |
8.6. Reanimator Inc. |
8.7. Cardiac Science Corporation |
8.8. Asahi Kasei Medical Co. |
8.9. HeartSine Technologies |
8.10. Everst Medical |
8.11. Micro Medical Devices |
8.12. Infinivault LLC |
8.13. Biotronik GmbH & Co. KG |
8.14. Vyaire Medical Inc. |
8.15. Defibtech LLC |
9. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Automated CPR Devices Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Automated CPR Devices Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Automated CPR Devices Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.
NA